20.02.2024 CompuGroup Medical SE & Co. KGaA  DE000A288904

EQS-Adhoc: General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase


 

EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend
General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase

20-Feb-2024 / 20:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase

Against the background of the stable financial and earnings position the general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend payment to a higher level. Therefore, the general partner plans to propose to the Annual General Meeting to increase the dividend per dividend bearing share to EUR 1.00 for the financial year 2023, compared to a dividend of EUR 0.50 per share for the financial year 2022.

The proposed dividend increase will be on the agenda of the Supervisory Board after the final financial statements for the financial year 2023 are available.

A dividend payment based on the final dividend proposal of the general partner and the Supervisory Board for the financial year 2023 is subject to the approval of the Annual General Meeting as well as further legal requirements.

CompuGroup Medical SE & Co. KGaA will publish the full Annual Report for the financial year 2023 as planned on March 28, 2024.

 

 



End of Inside Information

20-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1841405

 
End of Announcement EQS News Service

1841405  20-Feb-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1841405&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 98,00
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 8,25
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 14,040 Halten 754,43
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
12,00 34,38 0,35 12,02
KBV KCV KUV EV/EBITDA
1,23 4,20 0,64 6,24
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,50 1,00 7,12 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-6,27% -45,19% -62,96% -61,28%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP